Cohort profile: The Tromsø Study
TL;DR: The Tromso Study was initiated in 1974 in an attempt to help combat the high mortality of cardiovascular diseases in Norway, that was particularly pronounced among middle-aged men, and there are currently some 100 different ongoing research projects based on the data from the consecutive six surveys.
read more
Abstract: The Tromso Study was initiated in 1974 in an attempt to help combat the high mortality of cardiovascular diseases in Norway, that was particularly pronounced among middle-aged men. In the mid-1970s, Norwegian men had a 20% risk of dying of myocardial infarction (MI) before the age of 75 years. The situation in Northern Norway was even worse. The primary aim of the Tromso Study was to determine causes of the high cardiovascular mortality, and also to develop ways of preventing heart attacks and strokes. This was reflected through the first name of the study: The Tromso Heart Study. However, during the 37 years since the first examination of the Tromso Study took place, increasing emphasis has been put on other chronic diseases and conditions, in particular atrial fibrillation, venous thromboembolism, diabetes mellitus, osteoporosis and fractures. It has been a deliberate policy to invite a wide range of faculty research groups to join in with subprojects in the surveys, and there are currently some 100 different ongoing research projects based on the data from the consecutive six surveys. The study was initially funded by the University of Tromso, and has been so for the entire period since 1974, but there have also been substantial contributions, directly and indirectly from, for example, the National Screening Services, the Research Council of Norway, Northern Norway Regional Health Authority, Norwegian Council on Cardiovascular Diseases and Norwegian Foundation for Health and Rehabilitation. Teams of investigators approach public research programmes for funding of the different examinations conducted. Tromso is the largest city in Northern Norway. It is situated 400 km north of the Arctic Circle, and has approximately 67 000 inhabitants. The physical living conditions are dominated by dramatic changes in the light with 2 months of midnight sun and 2 months of the polar night. However, due to the Gulf Stream, the climate is relatively mild, the latitude (698N) taken into account.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
Emanuele Di Angelantonio,Shilpa N Bhupathiraju,David Wormser,Pei Gao,Pei Gao,Stephen Kaptoge,Amy Berrington de Gonzalez,Benjamin J Cairns,Rachel R. Huxley,Chandra L. Jackson,Grace Joshy,Sarah Lewington,JoAnn E. Manson,Neil Murphy,Alpa V. Patel,Jonathan M. Samet,Mark Woodward,Mark Woodward,Mark Woodward,Wei Zheng,Maigen Zhou,Narinder Bansal,Aurelio Barricarte,Brian D. Carter,James R. Cerhan,Rory Collins,George Davey Smith,Xianghua Fang,Oscar H. Franco,Jane Green,Jim Halsey,Janet S. Hildebrand,Keum Ji Jung,Rosemary J. Korda,Dale McLerran,Steven C. Moore,Linda M. O’Keeffe,Ellie Paige,Anna Ramond,Gillian K Reeves,Betsy Rolland,Carlotta Sacerdote,Naveed Sattar,Eleni Sofianopoulou,June Stevens,Michael J. Thun,Hirotsugu Ueshima,Ling Yang,Young Duk Yun,Peter Willeit,Peter Willeit,Emily Banks,Valerie Beral,Zhengming Chen,Susan M. Gapstur,Marc J. Gunter,Patricia Hartge,Sun Ha Jee,Tai Hing Lam,Richard Peto,John D. Potter,Walter C. Willett,Simon G. Thompson,John Danesh,Frank B. Hu +64 more
TL;DR: The associations of both overweight and obesity with higher all-cause mortality were broadly consistent in four continents and supports strategies to combat the entire spectrum of excess adiposity in many populations.
2.4K
Vitamin D deficiency in Europe: pandemic?
Kevin D. Cashman,Kirsten G. Dowling,Zuzana Škrabáková,Marcela González-Gross,Marcela González-Gross,Jara Valtueña,Stefaan De Henauw,Luis A. Moreno,Camilla T. Damsgaard,Kim F. Michaelsen,Christian Mølgaard,Rolf Jorde,Guri Grimnes,George Moschonis,Christina Mavrogianni,Yannis Manios,Michael Thamm,Gert B. M. Mensink,Martina Rabenberg,Markus A. Busch,Lorna Cox,Sarah Meadows,Gail R Goldberg,Ann Prentice,Jacqueline M. Dekker,Giel Nijpels,Stefan Pilz,Karin M. A. Swart,Natasja M. van Schoor,Paul Lips,Gudny Eiriksdottir,Vilmundur Gudnason,Mary Frances Cotch,Seppo Koskinen,Christel Lamberg-Allardt,Ramon Durazo-Arvizu,Christopher T. Sempos,Mairead Kiely +37 more
TL;DR: Vitamin D deficiency is evident throughout the European population at prevalence rates that are concerning and that require action from a public health perspective, and what direction these strategies take will depend on European policy.
1.1K
The evolving epidemiology of valvular aortic stenosis. The Tromsø Study
TL;DR: This is the first study to document the incidence and prognosis of AS in a general population with surgery as a treatment option, and reveals an accelerated progression of the aortic mean gradient as the disease advances.
614
Excess mortality after hip fracture in elderly persons from Europe and the USA : the CHANCES project.
Michail Katsoulis,Vassiliki Benetou,Tina Karapetyan,Diane Feskanich,Francine Grodstein,Ulrika Pettersson-Kymmer,Sture Eriksson,Tom Wilsgaard,Lone Jørgensen,Luai A. Ahmed,Ben Schöttker,Hermann Brenner,Andrea Bellavia,Alicja Wolk,Růžena Kubínová,B. Stegeman,Martin Bobak,Paolo Boffetta,Antonia Trichopoulou +18 more
TL;DR: Hip fractures are associated with diminished quality of life and survival especially amongst the elderly.
334
Representativeness of the LifeLines Cohort Study
TL;DR: The results suggest that the LifeLines adult study population is broadly representative for the adult population of the north of the Netherlands, and indicate that the risk of selection bias is low and that risk estimates in LifeL Lines can be generalized to the general population.
References
Major lipids, apolipoproteins, and risk of vascular disease
E Di Angelantonio,Nadeem Sarwar,P Perry,Stephen Kaptoge,Kausik K. Ray,Alexander J. Thompson,Angela M. Wood,Sarah Lewington,Naveed Sattar,Chris J. Packard,Rory Collins,Simon G. Thompson,John Danesh +12 more
TL;DR: Lid assessment in vascular disease can be simplified by measurement of either total and HDL cholesterol levels or apolipoproteins without the need to fast and without regard to triglyceride.
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
TL;DR: Estimates of the associations of major lipids and apolipoproteins in relation to coronary heart disease (CHD) and ischemic stroke are produced, incorporating adjustment for confounding caused by other risk factors and correction for regression dilution.
1.3K
The Tromso Heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.
TL;DR: The relationship of future clinical coronary heart-disease to the plasma-high-density-lipoprotein (H.H.D.L.)-cholesterol concentration has been examined in a 2-year case-control follow-up study of 6595 men aged 20-49 years living in the municipality of Tromsø, Norway and support the proposal that a low H.d.L. cholesterol concentration is important in accelerating the progression of coronary atherosclerosis.
1.2K
Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness
Inger Kristin Larsen,Milada Cvancarova Småstuen,Tom Børge Johannesen,Frøydis Langmark,Donald Maxwell Parkin,Freddie Bray,Bjørn Møller +6 more
TL;DR: The routines in place at the CRN yields comparable data that can be considered reasonably accurate, close-to-complete and timely, thereby justifying the policy of the reporting of annual incidence one year after the year of diagnosis.
836
Serum Total Homocysteine and Coronary Heart Disease
Egil Arnesen,Helga Refsum,Kaare H. Bønaa,Per Magne Ueland,Olav Helge Førde,Jan Erik Nordrehaug +5 more
TL;DR: In the general population serum total homocysteine is an independent risk factor for CHD with no threshold level, and there was no thresholdlevel above which serum homocy steine is associated with CHD events.
724